hotspot -WSS

hotspot

author：Wikipedia 2025-09-14 21:37:19 - browse：364

Akero Therapeutics said Tuesday that an experimental medicine failed to show a significant benefit for patients with cirrhosis caused by NASH, the most advanced and life-threatening stage of the fatty liver disease.

While the study’s primary goal of improving liver fibrosis, or scarring, was not achieved, the Akero drug, called efruxifermin, outperformed placebo by 10 percentage points. The drug also resolved NASH symptoms, including reductions in liver fat and inflammation, and improved other markers of the disease.

“These are the best data reported to date for any NASH drug in this patient population,” said Kitty Yale, Akero’s chief development officer. “We missed the primary endpoint. We understand that, but there’s actually a lot of hope when you look at the totality of the data.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： How to save health care price transparency rules

hotspot

WSS

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

President Biden's budget: Here's what you might have missed

HHS secretary Becerra pressed on Change HealthCare cyberattack

What to know about a major upcoming Wegovy heart health study

EPA limits use of carcinogenic gas for sterilizing medical devices

focus

hotspot

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

Medicare proposal to cover medical devices draws a mixed reaction

Sen. Bill Cassidy on how to lower drug prices

Affirmative action in medical school literally saved lives

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Boston's new lab space is opening empty

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How many hemophilia patients actually want gene therapy?

explore

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

How to save health care price transparency rules

How many hemophilia patients actually want gene therapy?

FDA advisers back CAR

How many hemophilia patients actually want gene therapy?

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

knowledge

hotspot

knowledge

focus